Trenton Todd Rees

Title: Trenton Todd Rees: Innovator in Leukocyte Isolation and Radiolabeling

Introduction

Trenton Todd Rees is a notable inventor based in Albuquerque, New Mexico. He has made significant contributions to the field of medical technology, particularly in the isolation and radiolabeling of leukocytes. His innovative methods have the potential to enhance various medical applications.

Latest Patents

Trenton Todd Rees holds a patent for a method titled "Method for isolating and radiolabeling leukocytes for use in vivo." This patent discloses a technique for separating leukocytes from platelets. The process involves adding blood serum to a centrifuge tube, followed by a suspension containing leukocytes and platelets. This mixture forms a layer on top of the blood serum, which has a lower density. The cells are then centrifuged to effectively separate the leukocytes from the platelets. The isolated leukocytes can be recovered from the centrifuge tube for further use. In some instances, the leukocyte cells are pretreated with a stannous ion reducing agent before being incubated with a technetium-99m (VII) salt solution to radiolabel the cells.

Career Highlights

Trenton Todd Rees has been associated with Syncor International Corporation, where he has applied his expertise in medical technology. His work has contributed to advancements in the field, particularly in the area of leukocyte manipulation for medical purposes.

Collaborations

Trenton has collaborated with Paul Richard Gotti, further enhancing the innovative efforts within their field. Their partnership has likely fostered new ideas and improvements in medical technology.

Conclusion

Trenton Todd Rees is a distinguished inventor whose work in leukocyte isolation and radiolabeling has the potential to impact medical practices significantly. His contributions through patents and collaborations reflect his commitment to advancing medical technology.